Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Administration of dendritic cells in cancer nodules in hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications[In vitro anti-myeloma effects induced by myeloma idiotype-protein pulsed dendritic cell vaccine]
/in Dendritic Cells, International Publications, Multiple MyelomaGenetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin’s lymphoma
/in International Publications, Malignant LymphomaThe immunotherapy of prostate and bladder cancer
/in International Publications, Urothelial CarcinomaSynergistic interaction of hyperthermia and Gemcitabine in lung cancer
/in International Publications, NSCLCDendritic cells pulsed with hsp70-peptide complexes derived from human hepatocellular carcinoma induce specific anti-tumor immune responses
/in Hepatocellular Carcinoma, International PublicationsVaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate
/in Dendritic Cells, International Publications, Malignant MelanomaB cell tumor vaccine enhanced by covalent attachment of immunoglobulin to surface proteins on dendritic cells
/in International Publications, Malignant LymphomaAllogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia
/in Chronic Leukemia, Dendritic Cells, International Publications[Current status of hyperthermia for therapy of brain tumor]
/in Glioblastoma, International PublicationsImmune-related effects of local hyperthermia in patients with primary liver cancer
/in Hepatocellular Carcinoma, International PublicationsImmune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon
/in International Publications, Malignant Melanoma[Vaccine therapy of prostate cancer]
/in International Publications, Prostate CancerB-cell lymphoma and myeloma protection induced by idiotype vaccination with dendritic cells is mediated entirely by T cells in mice
/in International Publications, Malignant LymphomaVaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial
/in Dendritic Cells, Hepatocellular Carcinoma, International PublicationsImmunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo
/in Dendritic Cells, International PublicationsAntitumor activity of a fusion of esophageal carcinoma cells with dendritic cells derived from cord blood
/in Esophageal Carcinoma, International PublicationsFirst results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma
/in Cervical Cancer, International PublicationsTumor-targeted gene transfer in vivo via recombinant Newcastle disease virus modified by a bispecific fusion protein
/in International Publications, Newcastle Disease VirusImmunotherapy in multiple myeloma–possibility or probability?
/in International Publications, Malignant Lymphoma